blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3464629

EP3464629 - IMMUNO-PETE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.07.2022
Database last updated on 24.04.2024
FormerThe patent has been granted
Status updated on  06.08.2021
FormerGrant of patent is intended
Status updated on  22.04.2021
FormerExamination is in progress
Status updated on  01.05.2020
FormerRequest for examination was made
Status updated on  08.03.2019
FormerThe international publication has been made
Status updated on  08.12.2017
Formerunknown
Status updated on  05.07.2017
Most recent event   Tooltip12.04.2024Lapse of the patent in a contracting state
New state(s): CY		published on 15.05.2024 [2024/20]
Applicant(s)For:AL  AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MK  MT  NL  NO  PL  PT  RO  RS  SE  SI  SK  SM  TR 
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
For:DE 
Roche Diagnostics GmbH
Sandhofer Strasse 116
68305 Mannheim / DE
[2019/15]
Inventor(s)01 / BERKA, Jan
3130 Half Dome Drive
Pleasanton, California 94566 / US
02 / GODWIN, Brian
2877 Caldeira Drive
Livermore, California 94550 / US
03 / DALLETT, Carolina
1625 Vista Street
Oakland, California 94602 / US
04 / OZTURK, Sedide
4289 Diavila Avenue
Pleasanton, California 94588 / US
05 / PLATZER, Joseph
5959 Skyline Boulevard
Oakland, California 94611 / US
06 / KIM, Seoyoung
733 Bounty Drive 204
Foster City, California 94404 / US
 [2019/15]
Representative(s)Burger, Alexander, et al
Roche Diagnostics GmbH
Patentabteilung
Nonnenwald 2
82377 Penzberg / DE
[2021/36]
Former [2019/15]Burger, Alexander, et al
Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O.Box 11 52
82372 Penzberg / DE
Application number, filing date17731966.201.06.2017
[2019/15]
WO2017US35516
Priority number, dateUS201662344330P01.06.2016         Original published format: US 201662344330 P
[2019/15]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2017210469
Date:07.12.2017
Language:EN
[2017/49]
Type: A2 Application without search report 
No.:EP3464629
Date:10.04.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 07.12.2017 takes the place of the publication of the European patent application.
[2019/15]
Type: B1 Patent specification 
No.:EP3464629
Date:08.09.2021
Language:EN
[2021/36]
Search report(s)International search report - published on:EP15.03.2018
ClassificationIPC:C12Q1/6881
[2021/19]
CPC:
C12Q1/6881 (EP,US); C40B50/06 (US); C12N15/1065 (US);
C12Q1/68 (EP,US); C12Q1/6886 (US); C12Q2600/16 (US)
C-Set:
C12Q1/68, C12Q2525/161, C12Q2525/186, C12Q2537/143 (EP,US)
Former IPC [2019/15]C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/15]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:IMMUNO-PETE[2019/15]
English:IMMUNO-PETE[2019/15]
French:IMMUNO-ENRICHISSEMENT DE CIBLE PAR EXTENSION D'AMORCE (IMMUNO-PETE)[2019/15]
Entry into regional phase02.01.2019National basic fee paid 
02.01.2019Designation fee(s) paid 
02.01.2019Examination fee paid 
Examination procedure02.01.2019Examination requested  [2019/15]
02.01.2019Date on which the examining division has become responsible
26.07.2019Amendment by applicant (claims and/or description)
07.05.2020Despatch of a communication from the examining division (Time limit: M04)
16.09.2020Reply to a communication from the examining division
07.12.2020Despatch of a communication from the examining division (Time limit: M01)
10.12.2020Reply to a communication from the examining division
23.04.2021Communication of intention to grant the patent
03.08.2021Fee for grant paid
03.08.2021Fee for publishing/printing paid
03.08.2021Receipt of the translation of the claim(s)
Opposition(s)09.06.2022No opposition filed within time limit [2022/33]
Fees paidRenewal fee
10.06.2019Renewal fee patent year 03
31.03.2020Renewal fee patent year 04
08.06.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.06.2017
AL08.09.2021
AT08.09.2021
CY08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE01.06.2022
LU01.06.2022
[2024/20]
Former [2024/18]HU01.06.2017
AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE01.06.2022
LU01.06.2022
Former [2023/21]AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE01.06.2022
LU01.06.2022
Former [2023/20]AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
IE01.06.2022
Former [2023/08]AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
MC08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/36]AL08.09.2021
AT08.09.2021
CZ08.09.2021
DK08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SI08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/29]AL08.09.2021
AT08.09.2021
CZ08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/25]AT08.09.2021
CZ08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SK08.09.2021
SM08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/24]AT08.09.2021
CZ08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
NL08.09.2021
PL08.09.2021
RO08.09.2021
RS08.09.2021
SE08.09.2021
SK08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
IS08.01.2022
PT10.01.2022
Former [2022/23]AT08.09.2021
CZ08.09.2021
EE08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
PL08.09.2021
RS08.09.2021
SE08.09.2021
SK08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
PT10.01.2022
Former [2022/21]AT08.09.2021
FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
RS08.09.2021
SE08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
Former [2022/10]FI08.09.2021
HR08.09.2021
LT08.09.2021
LV08.09.2021
RS08.09.2021
SE08.09.2021
BG08.12.2021
NO08.12.2021
GR09.12.2021
Former [2022/09]FI08.09.2021
LT08.09.2021
RS08.09.2021
SE08.09.2021
BG08.12.2021
NO08.12.2021
Former [2022/08]FI08.09.2021
LT08.09.2021
SE08.09.2021
BG08.12.2021
NO08.12.2021
Former [2022/07]LT08.09.2021
NO08.12.2021
Cited inInternational search[I]US2010330571  (ROBINS HARLAN S [US], et al) [I] 15-28 * paragraph [0057] - paragraph [0066] * * tables 1-5 *;
 [I]WO2012027503  (HUTCHINSON FRED CANCER RES [US], et al) [I] 1-14,29-33 * page 25, line 13 - line 21 * * page 33, line 9 - line 13 * * page 34, line 10 - line 25 * * page 45, line 9 - page 47, line 3 * * page 80, line 1 - line 9 * * claim 1 *;
 [I]WO2012048340  (HARVARD COLLEGE [US], et al) [I] 15-28 * paragraph [0105] - paragraph [0106] * * paragraph [0112] * * claims 1-35 *;
 [I]WO2013086450  (ADAPTIVE BIOTECHNOLOGIES CORP [US]) [I] 15-28 * claims 1-90 * * page 105 - page 111 *;
 [I]WO2014145992  (ADAPTIVE BIOTECHNOLOGIES CORP [US]) [I] 1-14,29-33 * paragraph [0128] * * paragraph [0153] - paragraph [0186] * * paragraph [0213] * * claim 1 *;
 [I]US2016138011  (DEWITT WILLIAM [US], et al) [I] 1-14,29-33 * paragraph [0016] * * paragraph [0027] * * paragraph [0034] * * paragraph [0135] * * claims 1,3-5, 7,16,18-20,24,25 *;
 [I]  - H. S. ROBINS ET AL, "Comprehensive assessment of T-cell receptor ?-chain diversity in ?? T cells", BLOOD, (20091105), vol. 114, no. 19, doi:10.1182/blood-2009-04-217604, ISSN 0006-4971, pages 4099 - 4107, XP055074444 [I] 15-28 * page 4100, column l, paragraph l *

DOI:   http://dx.doi.org/10.1182/blood-2009-04-217604
 [A]  - FEUCHTENBERGER M ET AL, "Semiquantitative and qualitative assessment of B-lymphocyte V"H repertoire by a fluorescent multiplex PCR", JOURNAL OF IMMUNOLOGICAL METH, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, (20030501), vol. 276, no. 1-2, doi:10.1016/S0022-1759(03)00101-7, ISSN 0022-1759, pages 121 - 127, XP004422646 [A] 1-33 * page 122, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/S0022-1759(03)00101-7
 [A]  - M. RITGEN, "Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia", BLOOD, (20021031), vol. 101, no. 5, doi:10.1182/blood-2002-06-1744, ISSN 0006-4971, pages 2049 - 2053, XP055162107 [A] 1-33 * page 2050, column l, paragraph l *

DOI:   http://dx.doi.org/10.1182/blood-2002-06-1744
 [A]  - PASQUAL N ET AL, "Quantitative and qualitative changes in V-J alpha rearrangements during mouse thymocytes differentiation: implication for a limited T cell receptor alpha chain repertoire", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, (20021104), vol. 196, no. 9, doi:10.1084/JEM.20021074, ISSN 0022-1007, pages 1163 - 1173, XP002322207 [A] 1-33 * page 1164, column r, paragraph l - page 1165, column l, paragraph l *

DOI:   http://dx.doi.org/10.1084/jem.20021074
by applicantUS4683202
 US4683195
 US4965188
 WO0132887
 US2010323348
 US8715967
    - BATZER et al., Nucleic Acid Res., (19910000), vol. 19, page 5081
    - OHTSUKA et al., J. Biol. Chem., (19850000), vol. 260, pages 2605 - 2608
    - ROSSOLINI et al., Mol. Cell. Probes, (19940000), vol. 8, pages 91 - 98
    - Sambrook et al., Molecular Cloning: A Laboratory Manual. 4th Ed., (20120000), vol. 1
    - GLANVILLE et al., PNAS, (20090000), vol. 106, no. 48, pages 20216 - 20221
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.